Citations

Clear

4610 citation(s) found for "Lu, Brian".

Perioperative Complications following Artificial Urinary Sphincter Placement
Linder, Brian J. , Piotrowski, Joshua, Ziegelmann, Matthew , Rivera, Marcelino , Rangel, Laureano J. , Elliott, Daniel S. , Piotrowski, Joshua T, Ziegelmann, Matthew J, Rivera, Marcelino E, Linder, Brian J

Mayo Clinic

Journal of Urology | March 14, 2015 | Volume: 194 | Issue: 3 | Pages: 716-720

10.1016/j.juro.2015.02.2945 | PMID 25776908 Get It

Intermediate and Long-term Outcomes of Giant Fibroadenoma Excision in Adolescent and Young Adult Patients
Cerrato, Felecia , Pruthi, Sandhya , Simmons, Patricia S., Salje, Barbara, Nuzzi, Laura C. , Lemaine, Valérie, Labow, Brian I. , Boughey, Judy C.

Mayo Clinic

The Breast Journal | March 14, 2015 | Volume: 21 | Issue: 3 | Pages: 254-259

10.1111/tbj.12394 | PMID 25772491 Get It

Neurolymphomatosis: A report of 2 cases representing opposite ends of the clinical spectrum
Lahoria, Rajat , Dyck, P. James B. , Macon, William R. , Spinner, Robert J. , Amrami, Kimberly K. , Zeldenrust, Steven R., Tracy, Jennifer A., Crum, Brian A.

Mayo Clinic

Muscle & Nerve | March 11, 2015 | Volume: 52 | Issue: 3 | Pages: 449-454

10.1002/mus.24646 | PMID 25758704 Get It

ABSTRACTIntroductionNeurolymphomatosis (NL) is a rare disorder characterized by invasion of cranial or peripheral nerves, nerve roots, or plexi, usually by aggressive subtypes of non‐Hodgkin lymphoma (NHL). The most common clinical presentation is that of a painful polyneuropathy or polyradiculopathy, followed by cranial neuropathy and, less frequently, by painless polyneuropathy.MethodsClinical and pathologic findings are reported for 2 NL cases.ResultsThe following 2 patients with NL, with disparate clinical presentations, are presented: a patient with subacute onset, painful, multifocal, mixed axonal and demyelinating radiculoplexus neuropathy due to a large B‐cell NHL, who required 2 targeted fascicular nerve biopsies to demonstrate NL; and a patient with a slowly progressive, length‐dependent axonal polyneuropathy due to a low‐grade B‐cell lymphoproliferative disorder, as shown on a diagnostic sural nerve biopsy.ConclusionsThe cases described illustrate the wide clinical spectrum of NL. Muscle Nerve 52:449–454, 2015
Treatment Planning and Fracture Prediction in Patients with Skeletal Metastasis with CT-Based Rigidity Analysis
Entezari, Vahid , Calderon, Nathan, Hipp, John A. , Villa‐Camacho, Juan C., Cheung, Felix H., Aboulafia, Albert J. , Turcotte, Robert , Anderson, Megan E. , Gebhardt, Mark C., Terek, Richard M. , Yaszemski, Michael J. , Snyder, Brian D. , Yaszemski, Michael, Nazarian, Ara , Zurakowski, David , Lin, Patrick P. , Cheng, Edward Y. , Damron, Timothy A.

Mayo Clinic

Clinical Cancer Research | February 27, 2015 | Volume: 21 | Issue: 11 | Pages: 2514-2519

10.1158/1078-0432.ccr-14-2668 | PMID 25724521 Get It

Abstract Purpose: Pathologic fractures could be prevented if reliable methods of fracture risk assessment were available. A multicenter prospective study was conducted to identify significant predictors of physicians' treatment plan for skeletal metastasis based on clinical fracture risk assessments and the proposed CT-based Rigidity Analysis (CTRA). Experimental Design: Orthopedic oncologists selected a treatment plan for 124 patients with 149 metastatic lesions based on the Mirels method. Then, CTRA was performed, and the results were provided to the physicians, who were asked to reassess their treatment plan. The pre- and post-CTRA treatment plans were compared to identify cases in which the treatment plan was changed based on the CTRA report. Patients were followed for a 4-month period to establish the incidence of pathologic fractures. Results: Pain, lesion type, and lesion size were significant predictors of the pre-CTRA plan. After providing the CTRA results, physicians changed their plan for 36 patients. CTRA results, pain, and primary source of metastasis were significant predictors of the post-CTRA plan. Follow-up of patients who did not undergo fixation resulted in 7 fractures; CTRA predicted these fractures with 100% sensitivity and 90% specificity, whereas the Mirels method was 71% sensitive and 50% specific. Conclusions: Lesion type and size and pain level influenced the physicians' plans for the management of metastatic lesions. Physicians' treatment plans and fracture risk predictions were significantly influenced by the availability of CTRA results. Due to its high sensitivity and specificity, CTRA could potentially be used as a screening method for pathologic fractures. Clin Cancer Res; 21(11); 2514–9. ©2015 AACR.
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer
DeMichele, Angela, Yee, Douglas , Berry, Donald A. , Albain, Kathy S. , Benz, Christopher C. , Buxton, Meredith , Chia, Stephen , Chien, A. Jo , Clark, Amy S. , Edmiston, Kirsten K., Forero‐Torres, Andres , Haddad, Tufia C. , Haley, Barbara , Haluska, Paul , Korde, Larissa A. , Leyland‐Jones, Brian , Liu, Minetta C. , Melisko, Michelle , Minton, Susan, Moulder, Stacy L. , Nanda, Rita , Olopade, Olufunmilayo I. , Paoloni, Melissa, Park, John W., Parker, Barbara A. , Perlmutter, Jane , Petricoin, Emanuel F. , Symmans, Fraser, Tripathy, Debasish , Veer, Laura J. van’t , Viscusi, Rebecca K., Symmans, W. Fraser , Boughey, Judy, Boughey, Judy C. , Hui, Jane Yuet Ching , Elias, Anthony , Hylton, Nola M. , Isaacs, Claudine , Kaplan, Henry G. , Rugo, Hope S. , Wallace, Anne M. , Wolf, Denise M. , Yau, Christina , Esserman, Laura J. , Olopade, Olufunmilayo I , Symmans, W Fraser , Yee, Douglas

Mayo Clinic

Clinical Cancer Research | February 26, 2015 | Volume: 21 | Issue: 13 | Pages: 2911-2915

10.1158/1078-0432.ccr-14-1760 | PMID 25712686 Get It

AbstractThe many improvements in breast cancer therapy in recent years have so lowered rates of recurrence that it is now difficult or impossible to conduct adequately powered adjuvant clinical trials. Given the many new drugs and potential synergistic combinations, the neoadjuvant approach has been used to test benefit of drug combinations in clinical trials of primary breast cancer. A recent FDA-led meta-analysis showed that pathologic complete response (pCR) predicts disease-free survival (DFS) within patients who have specific breast cancer subtypes. This meta-analysis motivated the FDA's draft guidance for using pCR as a surrogate endpoint in accelerated drug approval. Using pCR as a registration endpoint was challenged at ASCO 2014 Annual Meeting with the presentation of ALTTO, an adjuvant trial in HER2-positive breast cancer that showed a nonsignificant reduction in DFS hazard rate for adding lapatinib, a HER-family tyrosine kinase inhibitor, to trastuzumab and chemotherapy. This conclusion seemed to be inconsistent with the results of NeoALTTO, a neoadjuvant trial that found a statistical improvement in pCR rate for the identical lapatinib-containing regimen. We address differences in the two trials that may account for discordant conclusions. However, we use the FDA meta-analysis to show that there is no discordance at all between the observed pCR difference in NeoALTTO and the observed HR in ALTTO. This underscores the importance of appropriately modeling the two endpoints when designing clinical trials. The I-SPY 2/3 neoadjuvant trials exemplify this approach. Clin Cancer Res; 21(13); 2911–5. ©2015 AACR.
Novel biodegradable poly(propylene fumarate)-co-poly( l -lactic acid) porous scaffolds fabricated by phase separation for tissue engineering applications
Liu, Xifeng , Waletzki, Brian E., Yaszemski, Michael J. , Lu, Lichun , Miller, A. Lee , Miller, Alan Lee

Mayo Clinic

RSC Advances | February 17, 2015 | Volume: 5 | Issue: 27 | Pages: 21301-21309

10.1039/c5ra00508f | PMID 26989483 Get It

Three-dimensional polymer scaffolds with interconnected porous structures were fabricated by thermally induced phase separation of novel biodegradable poly(propylene fumarate)- co -poly( l -lactic acid).
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
Palumbo, Antonio , Bringhen, Sara , Mateos, María‐Victoria , Larocca, Alessandra , Kumar, Shaji , Offidani, Massimo , Evangelista, Andrea , Zweegman, Sonja , Musto, Pellegrino , Terpos, Evangelos , Belch, Andrew , Hájek, Roman , Stewart, A. Keith, Moreau, Philippe , Durie, Brian G.M. , Dimopoulos, Meletios Α. , Miguel, Jesús F. San , Richardson, Paul G. , Sonneveld, Pieter , Facon, Thierry T.F. , McCarthy, Philip L. , Lonial, Sagar , Zweegman, Sonja , Ludwig, Heinz , Anderson, Kenneth C. , Einsele, Hermann , Landgren, Ola , Richardson, Paul Gerard Guy , Rajkumar, S. Vincent , Hajek, Roman , Dimopoulos, Meletios A , Moreau, Philippe , Terpos, Evangelos , San-Miguel, Jesus

Mayo Clinic

Blood | January 28, 2015 | Volume: 125 | Issue: 13 | Pages: 2068-2074

10.1182/blood-2014-12-615187 | PMID 25628469 Get It

Key Points Elderly patients with myeloma are heterogeneous and assessment strategies are needed to define the frailty profile. The proposed frailty score aims to better assess patients and provide them with more suitable therapies.
MEN1 Mutations in Hürthle Cell (Oncocytic) Thyroid Carcinoma
Kasaian, Katayoon, Chindris, Ana-Maria, Wiseman, Sam M. , Mungall, Karen , Zeng, Thomas, Tse, Kane, Schein, Jacqueline E., Rivera, Michael , Necela, Brian M. , Kachergus, Jennifer M., Casler, John D., Mungall, Andrew J. , Moore, Richard A. , Marra, Marco A. , Copland, John A. , Thompson, E. Aubrey , Smallridge, Robert C., Jones, Steven J.M. , Kasaian, Katayoon, Chindris, Ana-Maria , Mungall, Andrew J

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | January 27, 2015 | Volume: 100 | Issue: 4 | Pages: E611-E615

10.1210/jc.2014-3622 | PMID 25625803 Get It

Context and Objective:Oncocytic thyroid carcinoma, also known as Hürthle cell thyroid carcinoma, accounts for only a small percentage of all thyroid cancers. However, this malignancy often presents at an advanced stage and poses unique challenges to patients and clinicians. Surgical resection of the tumor accompanied in some cases by radioactive iodine treatment, radiation, and chemotherapy are the established modes of therapy. Knowledge of the perturbed oncogenic pathways can provide better understanding of the mechanism of disease and thus opportunities for more effective clinical management.Design and Patients:Initially, two oncocytic thyroid carcinomas and their matched normal tissues were profiled using whole genome sequencing. Subsequently, 72 oncocytic thyroid carcinomas, one cell line, and five Hürthle cell adenomas were examined by targeted sequencing for the presence of mutations in the multiple endocrine neoplasia I (MEN1) gene.Results:Here we report the identification of MEN1 loss-of-function mutations in 4% of patients diagnosed with oncocytic thyroid carcinoma. Whole genome sequence data also revealed large regions of copy number variation encompassing nearly the entire genomes of these tumors.Conclusion:Menin, a ubiquitously expressed nuclear protein, is a well-characterized tumor suppressor whose loss is the cause of MEN1 syndrome. Menin is involved in several major cellular pathways such as regulation of transcription, control of cell cycle, apoptosis, and DNA damage repair pathways. Mutations of this gene in a subset of Hürthle cell tumors point to a potential role for this protein and its associated pathways in thyroid tumorigenesis.
Applying Cost Accounting to Operating Room Staffing in Otolaryngology
Balakrishnan, Karthik , Goico, Brian, Arjmand, Ellis M., Balakrishnan, Karthik

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 26, 2015 | Volume: 152 | Issue: 4 | Pages: 684-690

10.1177/0194599814568273 | PMID 25623288 Get It

Objectives(1) To describe the application of a detailed cost‐accounting method (time‐driven activity‐cased costing) to operating room personnel costs, avoiding the proxy use of hospital and provider charges. (2) To model potential cost efficiencies using different staffing models with the case study of outpatient adenotonsillectomy.Study DesignProspective cost analysis case study.SettingTertiary pediatric hospital.Subject and MethodsAll otolaryngology providers and otolaryngology operating room staff at our institution.ResultsTime‐driven activity‐based costing demonstrated precise per‐case and per‐minute calculation of personnel costs. We identified several areas of unused personnel capacity in a basic staffing model. Per‐case personnel costs decreased by 23.2% by allowing a surgeon to run 2 operating rooms, despite doubling all other staff. Further cost reductions up to a total of 26.4% were predicted with additional staffing rearrangements.ConclusionTime‐driven activity‐based costing allows detailed understanding of not only personnel costs but also how personnel time is used. This in turn allows testing of alternative staffing models to decrease unused personnel capacity and increase efficiency.